Andrew Piggott

Dr. Andrew Piggott

Department of Molecular Sciences, Macquarie University, Sydney, Australia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2009 in Journal of Natural Products
Verified
Journal Article
Closed access
LFLeith J. Fremlin
Leith J. Fremlin
Andrew PiggottAndrew Piggott
Andrew Piggott
ELErnest Lacey
Ernest Lacey
RCRobert. J. Capon
Robert. J. Capon

10 September 2012 in Organic Letters
Verified
Journal Article
Closed access
FSFuhang Song
Fuhang Song
XLXinru Liu
Xinru Liu
HGHui Guo
Hui Guo
BRBiao Ren
Biao Ren
CCCaixia Chen
Caixia Chen
Rob CaponRob Capon
Rob Capon

6 December 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
QWQian Wang
Qian Wang
FSFuhang Song
Fuhang Song
XXXue Xiao
Xue Xiao
PHPei Huang
Pei Huang
LLLi Li
Li Li
LZLixin Zhang
Lixin Zhang
From the deep: The title actinomycete yielded three new abyssomicins J–L. The dimeric thioether J (see scheme) represents a unique example of a masked Michael acceptor with anti‐TB properties. Mechanistic insights into the biosynthesis, biomimetic synthesis, stability, and biological mechanism of action of abyssomicins aid our understanding of, and prospects for the development of Michael‐acceptor‐based drugs.

22 April 2011 in Organic Letters
Verified
Journal Article
Closed access
RRRitesh Raju
Ritesh Raju
Andrew PiggottAndrew Piggott
Andrew Piggott
XHXiao-Cong Huang
Xiao-Cong Huang
RCRobert J. Capon
Robert J. Capon

1 December 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KCKwang-Jin Cho
Kwang-Jin Cho
JPJin-Hee Park
Jin-Hee Park
Andrew PiggottAndrew Piggott
Andrew Piggott
ASAngela A Salim
Angela A Salim
AGAlemaheyu A. Gorfe
Alemaheyu A. Gorfe
JHJohn F Hancock
John F Hancock
Oncogenic mutant Ras is frequently expressed in human cancers, but no anti-Ras drugs have been developed. Since membrane association is essential for Ras biological activity, we developed a high content assay for inhibitors of Ras plasma membrane localization. We discovered that staurosporine and analogs potently inhibit Ras plasma membrane binding by blocking endosomal recycling of phosphatidylserine, resulting in redistribution of phosphatidylserine from plasma membrane to endomembrane. Staurosporines are more active against K-Ras than H-Ras. K-Ras is displaced to endosomes and undergoes proteasomal-independent degradation, whereas H-Ras redistributes to the Golgi and is not degraded. K-Ras nanoclustering on the plasma membrane is also inhibited. Ras mislocalization does not correlate with protein kinase C inhibition or induction of apoptosis. Staurosporines selectively abrogate K-Ras signaling and proliferation of K-Ras-transformed cells. These results identify staurosporines as novel inhibitors of phosphatidylserine trafficking, yield new insights into the role of phosphatidylserine and electrostatics in Ras plasma membrane targeting, and validate a new target for anti-Ras therapeutics.

22 November 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
JHJinyu Hu
Jinyu Hu
FSFarzaneh Sarrami
Farzaneh Sarrami
HLHang Li
Hang Li
GZGuozhi Zhang
Guozhi Zhang
KSKeith Stubbs
Keith Stubbs
YCYit-Heng Chooi
Yit-Heng Chooi
Perylenequinones are a class of aromatic polyketides characterised by a highly conjugated pentacyclic core, which confers them with potent light-induced bioactivities and unique photophysical properties. Despite the biosynthetic gene clusters for the perylenequinones elsinochrome A (1), cercosporin (4) and hypocrellin A (6) being recently identified, key biosynthetic aspects remain elusive. Here, we first expressed the intact elc gene cluster encoding 1 from the wheat pathogen Parastagonospora nodorum heterologously in Aspergillus nidulans on a yeast-fungal artificial chromosome (YFAC). This led to the identification of a novel flavin-dependent monooxygenase, ElcH, responsible for oxidative enolate coupling of a perylenequinone intermediate to the hexacyclic dihydrobenzo(ghi)perylenequinone in 1. In the absence of ElcH, the perylenequione intermediate formed a hexacyclic cyclohepta(ghi)perylenequinone system via an intramolecular aldol reaction resulting in 6 and a novel hypocrellin 12 with opposite helicity to 1. Theoretical calculations supported that 6 and 12 resulted from atropisomerisation upon formation of the 7-membered ring. Using a bottom-up pathway reconstruction approach on a tripartite YFAC system developed in this study, we uncovered that both a berberine bridge enzyme-like oxidase ElcE and a laccase-like multicopper oxidase ElcG are involved in the double coupling of two naphthol intermediates to form the perylenequinone core. Gene swapping with the homologs from the biosynthetic pathway of 4 showed that cognate pairing of the two classes of oxidases is required for the formation of the perylenequinone core, suggesting the involvement of protein–protein interactions.